Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ), Health Subcommittee Chairwoman Anna G. Eshoo (D-CA) and Oversight and Investigations Subcommittee Chair Diana DeGette (D-CO) today announced plans to investigate the impacts the U.S. Postal Service’s organizational and operational changes are having on the safe and timely delivery of prescription drugs, particularly in the midst of the coronavirus disease of 2019 (COVID-19) pandemic:
“The Trump Administration’s abrupt and sweeping operational changes at the Postal Service are severely delaying mail all around the nation. These delays are troubling across the board, but especially during a time when Americans are increasingly relying on mail services as a result of the COVID-19 pandemic. At a time when the nation’s public health is already under significant threat, we’re deeply concerned and plan to investigate the impacts the Administration’s changes are having on the delivery of lifesaving prescription drugs to patients.
“In the coming days, we’re going to be asking online pharmacies, pharmacy benefit managers and the relevant trade associations about the impacts the Postal Service’s delays are having on getting lifesaving drugs to beneficiaries in a timely fashion. We want to know what these organizations are hearing and what needs to be done to ensure Americans receive their medication without delay and without any additional costs."
